MAPK1 and colorectal carcinoma: Accordingly, overexpression and constitutive activation of MAPK/ERK pathway has been reported in the carcinogenesis, migration, invasion and metastasis of CRC [35] and its components, as a potentially useful target for CRC treatment [109].